NEWS and OPINIONS
Researchers have developed a tiny, 3D-printed cell “cradle” to boost IVF success, with the treatment of cancer, diabetes, cystic fibrosis and spinal cord injury also advanced by the invention.
By Lynne Minion – HealthcareITNews A tiny new medical device has been developed by Australian researchers that will transform the only fertility treatment procedure available for men with low sperm counts, with implications for the success of IVF and beyond into...
California cosmetic surgeon, Mark Berman, pusher of unproven stem cell therapies, dies while awaiting verdict in #FDA lawsuit.
By Michael Hiltzik - Business Columnist Los Angeles Times For years, California cosmetic surgeon Mark Berman was a leader of that corner of the healthcare world pushing unproven and unapproved stem cell treatments for a host of medical conditions. Berman aired his...
Video Premiere of 2022 Stem Cell & Regenerative Medicine Action Awards
On June 9 at 7:00 PM EDT, Regenerative Medicine Foundation (RMF) broadcast the Stem Cell and Regenerative Medicine Action Awards as part of the combined virtual 17th annual World Stem Cell Summit (WSCS) and Wake Forest Institute for Regenerative Medicine and RMF’s...
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
<h3>The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.</h3> By Antonio Regalado technologyreview.com - <a...
Cell Bridge Strategies Sponsors “Regenerative Medicine and Cell Therapy – The India Landscape” Session at Virtual World Stem Cell Summit, June 6-11
Boerne, TX. June 1, 2022 — Cell Bridge Strategies, an industry thought leader and consulting firm for Regenerative Medicine and the Advanced Therapies announced its sponsorship and design of an executive-level panel session to address the significant impact India is...
The power of the patient advocate: how a quick visit led to an $11M grant to fund a clinical trial
By Kevin McCormack - Link to article - CIRM At the California Institute for Regenerative Medicine (CIRM) we are fortunate in having enough money to fund the most promising research to be tested in a clinical trial. Those are expensive projects, often costing tens of...
Regenerative Medicine Foundation (RMF) Proudly Presents The 2022 “Stem Cell and Regenerative Medicine Action Award” Honorees
2022 Honorees include Arnold I. Caplan, PhD; Dr. Mahendra Rao; Frances Verter, PhD & The Parent’s Guide to Cord Blood Foundation and the Maryland Stem Cell Research Fund On June 9 at 7:00 PM EDT, Regenerative Medicine Foundation (RMF) will broadcast the Stem Cell...
Rejuvenating human beings: the rise of cellular reprogramming
Cellular reprogramming is on the up as a growing number of companies race to develop therapies for rejuvenating human beings. Author: Eleanor Garth - Longevity.Technology - Link to article Recent advances in cellular reprogramming have revolutionised the fields of...
Key Protein Identified for Brain Stem Cell Longevity
Cell receptor protein also stimulates the growth of brain cancer stem cells in Rutgers study By Kitta MacPherson - Rutgers Today - Link to article A receptor that was first identified as necessary for insulin action, that also is located on the neural stem cells found...
Six Awesome Things About 2022 Program
SIX AWESOME THINGS ABOUT 2022 PROGRAM Arnold I. Caplan MD, the "father" of MSCs, delivers a resounding keynote speech that will rock the Richter scale: “Physicians, Hear Me Now. MSCs Will Change How Medicine Is Practiced!” Beth Roxland, JD...
Cell Bridge Strategies Achieves Premier Consultant Firm Status at Virtual World Stem Cell Summit, June 6-11, 2022
Boerne, TX. May 11, 2022 — Cell Bridge Strategies, an industry thought leader and business consulting firm for regenerative medicine today announced its partnership and significant role at this year’s World Stem Cell Summit, taking place virtually on June 6-11,...
Stem cells could help prevent diabetes onset from cancer immunotherapy
By Michael Irving May 08, 2022 - Type 1 diabetes can be a rare but serious side effect of a cancer treatment that use what are known as immune checkpoint inhibitors. In a new study in mice, researchers in Japan have shown that administering stem cell therapy could...